T細胞リンパ腫治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2938)
◆英語タイトル:Global T-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2938
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、T細胞リンパ腫治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(化学療法、放射線療法、外科療法、幹細胞移植療法、その他)、用途別市場規模(病院、診療所、外来手術センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・T細胞リンパ腫治療の市場動向
・企業の競争状況、市場シェア
・T細胞リンパ腫治療の種類別市場規模(化学療法、放射線療法、外科療法、幹細胞移植療法、その他)
・T細胞リンパ腫治療の用途別市場規模(病院、診療所、外来手術センター、その他)
・T細胞リンパ腫治療の北米市場規模2016-2027(アメリカ、カナダ)
・T細胞リンパ腫治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・T細胞リンパ腫治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・T細胞リンパ腫治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・T細胞リンパ腫治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(BioCryst Pharmaceuticals、Johnson & Johnson、Novartis、Merck、Bristol-Myers Squibb、Genmab AS、Shionogi、Spectrum Pharmaceuticals、Seattle Genetics、Shenzhen ChipScreen Biosciences, Ltd.、Medivir AB、Amgen、Eisai Co., Ltd.、Sorrento Therapeutics)
・結論
【レポートの概要】

Market Analysis and Insights: Global T-Cell Lymphoma Treatment Market
The global T-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T-Cell Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global T-Cell Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global T-Cell Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global T-Cell Lymphoma Treatment market.

Global T-Cell Lymphoma Treatment Scope and Market Size
T-Cell Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiation Therapy
Surgical Therapy
Stem Cell Transplantation Therapy
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioCryst Pharmaceuticals
Johnson & Johnson
Novartis
Merck
Bristol-Myers Squibb
Genmab AS
Shionogi
Spectrum Pharmaceuticals
Seattle Genetics
Shenzhen ChipScreen Biosciences, Ltd.
Medivir AB
Amgen
Eisai Co., Ltd.
Sorrento Therapeutics

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Surgical Therapy
1.2.5 Stem Cell Transplantation Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global T-Cell Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global T-Cell Lymphoma Treatment Market Perspective (2016-2027)
2.2 T-Cell Lymphoma Treatment Growth Trends by Regions
2.2.1 T-Cell Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T-Cell Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 T-Cell Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 T-Cell Lymphoma Treatment Industry Dynamic
2.3.1 T-Cell Lymphoma Treatment Market Trends
2.3.2 T-Cell Lymphoma Treatment Market Drivers
2.3.3 T-Cell Lymphoma Treatment Market Challenges
2.3.4 T-Cell Lymphoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top T-Cell Lymphoma Treatment Players by Revenue
3.1.1 Global Top T-Cell Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global T-Cell Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global T-Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T-Cell Lymphoma Treatment Revenue
3.4 Global T-Cell Lymphoma Treatment Market Concentration Ratio
3.4.1 Global T-Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Lymphoma Treatment Revenue in 2020
3.5 T-Cell Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players T-Cell Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into T-Cell Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Lymphoma Treatment Breakdown Data by Type
4.1 Global T-Cell Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global T-Cell Lymphoma Treatment Forecasted Market Size by Type (2022-2027)

5 T-Cell Lymphoma Treatment Breakdown Data by Application
5.1 Global T-Cell Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global T-Cell Lymphoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America T-Cell Lymphoma Treatment Market Size (2016-2027)
6.2 North America T-Cell Lymphoma Treatment Market Size by Type
6.2.1 North America T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America T-Cell Lymphoma Treatment Market Size by Application
6.3.1 North America T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America T-Cell Lymphoma Treatment Market Size by Country
6.4.1 North America T-Cell Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America T-Cell Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe T-Cell Lymphoma Treatment Market Size (2016-2027)
7.2 Europe T-Cell Lymphoma Treatment Market Size by Type
7.2.1 Europe T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe T-Cell Lymphoma Treatment Market Size by Application
7.3.1 Europe T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe T-Cell Lymphoma Treatment Market Size by Country
7.4.1 Europe T-Cell Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe T-Cell Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific T-Cell Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America T-Cell Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America T-Cell Lymphoma Treatment Market Size by Type
9.2.1 Latin America T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America T-Cell Lymphoma Treatment Market Size by Application
9.3.1 Latin America T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America T-Cell Lymphoma Treatment Market Size by Country
9.4.1 Latin America T-Cell Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America T-Cell Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa T-Cell Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioCryst Pharmaceuticals
11.1.1 BioCryst Pharmaceuticals Company Details
11.1.2 BioCryst Pharmaceuticals Business Overview
11.1.3 BioCryst Pharmaceuticals T-Cell Lymphoma Treatment Introduction
11.1.4 BioCryst Pharmaceuticals Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.1.5 BioCryst Pharmaceuticals Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson T-Cell Lymphoma Treatment Introduction
11.2.4 Johnson & Johnson Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis T-Cell Lymphoma Treatment Introduction
11.3.4 Novartis Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck T-Cell Lymphoma Treatment Introduction
11.4.4 Merck Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb T-Cell Lymphoma Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Genmab AS
11.6.1 Genmab AS Company Details
11.6.2 Genmab AS Business Overview
11.6.3 Genmab AS T-Cell Lymphoma Treatment Introduction
11.6.4 Genmab AS Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.6.5 Genmab AS Recent Development
11.7 Shionogi
11.7.1 Shionogi Company Details
11.7.2 Shionogi Business Overview
11.7.3 Shionogi T-Cell Lymphoma Treatment Introduction
11.7.4 Shionogi Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.7.5 Shionogi Recent Development
11.8 Spectrum Pharmaceuticals
11.8.1 Spectrum Pharmaceuticals Company Details
11.8.2 Spectrum Pharmaceuticals Business Overview
11.8.3 Spectrum Pharmaceuticals T-Cell Lymphoma Treatment Introduction
11.8.4 Spectrum Pharmaceuticals Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.8.5 Spectrum Pharmaceuticals Recent Development
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Details
11.9.2 Seattle Genetics Business Overview
11.9.3 Seattle Genetics T-Cell Lymphoma Treatment Introduction
11.9.4 Seattle Genetics Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.9.5 Seattle Genetics Recent Development
11.10 Shenzhen ChipScreen Biosciences, Ltd.
11.10.1 Shenzhen ChipScreen Biosciences, Ltd. Company Details
11.10.2 Shenzhen ChipScreen Biosciences, Ltd. Business Overview
11.10.3 Shenzhen ChipScreen Biosciences, Ltd. T-Cell Lymphoma Treatment Introduction
11.10.4 Shenzhen ChipScreen Biosciences, Ltd. Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.10.5 Shenzhen ChipScreen Biosciences, Ltd. Recent Development
11.11 Medivir AB
11.11.1 Medivir AB Company Details
11.11.2 Medivir AB Business Overview
11.11.3 Medivir AB T-Cell Lymphoma Treatment Introduction
11.11.4 Medivir AB Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.11.5 Medivir AB Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen T-Cell Lymphoma Treatment Introduction
11.12.4 Amgen Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.12.5 Amgen Recent Development
11.13 Eisai Co., Ltd.
11.13.1 Eisai Co., Ltd. Company Details
11.13.2 Eisai Co., Ltd. Business Overview
11.13.3 Eisai Co., Ltd. T-Cell Lymphoma Treatment Introduction
11.13.4 Eisai Co., Ltd. Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.13.5 Eisai Co., Ltd. Recent Development
11.14 Sorrento Therapeutics
11.14.1 Sorrento Therapeutics Company Details
11.14.2 Sorrento Therapeutics Business Overview
11.14.3 Sorrento Therapeutics T-Cell Lymphoma Treatment Introduction
11.14.4 Sorrento Therapeutics Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.14.5 Sorrento Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ T細胞リンパ腫治療の世界市場規模・現状・予測2021年-2027年(Global T-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。